Medical Device & Healthcare
Requirements in the area of medical technology are becoming increasingly complex. With Zühlke as a partner, manufacturers can modernise their processes and products with the help of digital, data-driven technologies. In this way, your medical devices can become the central element of the patient journey.
Despite increased global competition and faster innovation cycles, MedTech companies can continue to excel in their core businesses. But when time-to-market is critical and knowledge gaps pose significant risks, the development of medical-grade products is no easy feat. It requires multi-disciplinary experience and proven processes.
With more than 50 years of experience in the medical market, Zühlke offers just that. We orchestrate experts in mechanics, electronics and software in well-oiled project teams to develop state-of-the-art devices for the global MedTech and healthcare market. Our comprehensive service includes design control, risk management and GxP-compliant production support. To make post-market surveillance and maintenance much easier, we also help you connect your products to the rest of the world – in full accordance with the applicable standards and regulations.
As innovation and product cycles pick up speed, our turnkey approach delivers marketable products quickly and safely – to help keep your business ahead of the pack.
WALK THE TALK
Eppendorf, a leading global company in the life sciences industry, wants to increase its innovation power and secure high, profitable growth. Zühlke is helping to increase the market efficiency by means of agile development. Learn how we walked the talk!
Fast-growing competitors pose a threat to incumbent MedTech companies. These new players are increasingly innovative, despite maintaining their cost advantages and pricing structures. At the same time, the regulatory demands on new medical products continue to rise. This makes it increasingly difficult for incumbents to break into new markets.
Zühlke helps you manage these complex challenges as you develop a portfolio to face down all comers. With the help of our SMEs, you can establish modular system architectures that differentiate products for different markets as well as update-and-upgrade concepts that enhance product longevity. As a Zühlke partner, you benefit from our in-depth understanding of the entire development lifecycle and our value engineering (cost reduction) methodology, in addition to our regulatory and technological expertise. With the state-of-the-art, cost-effective and compliant medical products we build together, you’ll be best positioned to succeed in dedicated – and highly competitive – global markets.
Data-driven innovation can deliver improved prevention, prediction and treatment. This presents MedTech companies with an opportunity – to successfully guide patients along a patient journey that optimises visits to physicians and hospitals. But a data-driven approach depends on smart investment decisions, which require a solid understanding of patient needs, connected devices, digital biomarkers, wearables, AI-based diagnostics and prediction – as well as secure and compliant cloud architectures integrated into hospital infrastructure.
Zühlke guides you through the jungle of product definition and digital technologies. As your expert partner, we give you access to multi-disciplined teams and proven engineering methods – including user and customer-experience prototypes. By helping you make the right investments at the right time, we ensure your patient-centred, data-driven ecosystem is a business success.
WALK THE TALK
Advanced Osteotomy Tools (AOT) develops the world’s first medical device to cut bones contact-free. Zühlke supports AOT with deep learning computer vision technology and creates a production-ready data platform. Learn how we walked the talk!
In addition to patient safety, governments and health insurers are increasingly focused on value-based healthcare and reliant on measurable therapy outcomes to keep health budgets under control. In response, MedTech companies that aim to provide holistic solutions must first embrace the collection of sensitive data via direct-to-consumer applications, which can monitor patients and therapies in real-time.
If you want to lead the future of value-based healthcare, Zühlke will help you invent it. We have the expertise to create novel solutions on your behalf – from developing the business model and an appealing user experience to building medical-grade apps and secure, connected devices that support AI-based data evaluation. This enables you to proactively support new reimbursement models for healthcare providers, pharma, payers and governments as well as, ultimately, for patients themselves.
Personalised healthcare and diagnostics require sophisticated biosensors and biomarkers. Consumer devices have a decisive role to play in the collection and meaningful analysis of these data – in the form of diagnostics, predictions and patient guidance. Medical-grade software and stand-alone medical applications can enhance existing consumer products, by incorporating the user-centricity developed and practiced by Big Tech. In this way, MedTech companies can create closed, holistic solutions that build on their existing expertise.
Zühlke can develop biosensors and automate biological processes as required. With the application of intelligent technologies, we also enable you to leverage your sensor data, giving you real-time control of your devices and ensuring secure connectivity. By offering consumers meaningful information and services, you can generate new revenue streams.
WALK THE TALK
Healios develops digital biomarkers to both improve the journey for patients suffering from Multiple Sclerosis and to accelerate research in this space. Interview with Guilhem Dupont, CEO of Zühlke Ventures’ youngest Portfolio Company Healios. Learn how we walked the talk!
Aud Frese is Senior Business Development Manager and Market Team Leader – Medical Technology & Healthcare Industry in the Zühlke Group. Her focus is on digital innovation, business strategies and product development. Aud Frese has a degree in Medical Informatics and has many years of experience in medical technology and the health sector.
Albert Frömel is responsible for the Healthcare & Life Sciences sector in Austria He draws on years of experience with leading national and international health institutions. In doing so, he actively helped shape the solution to the most important digital challenges. His focus is on digital transformation, new intelligence systems and data-driven ecosystems. Together with his team, he empowers his clients to improve patient health outcomes, modernize work environments and ensure future-proof business models. Albert Frömel completes his technical education with a degree from the Vienna University of Economics and Business Administration and regularly gives lectures at conferences.
Bardia M. Zanganeh
Bardia M. Zanganeh is responsible for the Life Sciences and Healthcare practice in Switzerland. He serves leading healthcare institutions on all technology agenda issues. His primary areas of focus include digital innovation, business model transformation and product innovation. He also serves providers as well as medical technology and pharmaceutical companies. He has a background in engineering, consulting and entrepreneurship and is a lecturer at the University of Applied Sciences in Business Administration in Zurich.
Nicolas oversees the Healthcare and MedTech vertical at Zuhlke Singapore. As part of the Business Development team, he works on digital innovation initiatives together with both global and local customers. Nicolas finds joy in helping clients connect the dots, from conceptualisation to creation of exciting products.